| Title: | Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank |
| Journal: | BMC Medicine |
| Published: | 13 May 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38735950/ |
| DOI: | https://doi.org/10.1186/s12916-024-03418-8 |
| URL: | https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-024-03418-8 |
| Citations: | 2 (2 in last 2 years) as of 8 Aug 2024 |
Publication 12093
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundPeripheral glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) are sensitive markers of neuroinflammation and neuronal damage. Previous studies with highly selected participants have shown that peripheral GFAP and NfL levels are elevated in the pre-clinical phase of Alzheimer's disease (AD) and dementia. However, the predictive value of GFAP and NfL for dementia requires more evidence from population-based cohorts.MethodsThis was a prospective cohort study to evaluate UK Biobank participants enrolled from 2006 to 2010 using plasma GFAP and NfL measurements measured by Olink Target Platform and prospectively followed up for dementia diagnosis. Primary outcome was the risk of clinical diagnosed dementia. Secondary outcomes were cognition. Linear regression was used to assess the associations between peripheral GFAP and NfL with cognition. Cox proportional hazard models with cross-validations were used to estimate associations between elevated GFAP and NfL with risk of dementia. All models were adjusted for covariates.ResultsA subsample of 48,542 participants in the UK Biobank with peripheral GFAP and NfL measurements were evaluated. With an average follow-up of 13.18 ± 2.42 years, 1312 new all-cause dementia cases were identified. Peripheral GFAP and NfL increased up to 15 years before dementia diagnosis was made. After strictly adjusting for confounders, increment in NfL was found to be associated with decreased numeric memory and prolonged reaction time. A greater annualized rate of change in GFAP was significantly associated with faster global cognitive decline. Elevation of GFAP (hazard ratio (HR) ranges from 2.25 to 3.15) and NfL (HR ranges from 1.98 to 4.23) increased the risk for several types of dementia. GFAP and NfL significantly improved the predictive values for dementia using previous models (area under the curve (AUC) ranges from 0.80 to 0.89, C-index ranges from 0.86 to 0.91). The AD genetic risk score and number of APOE*E4 alleles strongly correlated with GFAP and NfL levels.ConclusionsThese results suggest that peripheral GFAP and NfL are potential biomarkers for the early diagnosis of dementia. In addition, anti-inflammatory therapies in the initial stages of dementia may have potential benefits.</p>
13 Keywords
- Aged
- Biomarkers
- Dementia
- Female
- Glial Fibrillary Acidic Protein
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Neurofilament Proteins
- Prospective Studies
- UK Biobank
- United Kingdom
5 Authors
- Xiaofei Wang
- Ziyan Shi
- Yuhan Qiu
- Dongren Sun
- Hongyu Zhou
1 Application
| Application ID | Title |
|---|---|
| 98826 | Revisit the phenotype of multiple sclerosis |
Enabling scientific discoveries that improve human health